title: Neuropsychiatric symptoms during treatment with interleukin-2 and interferon-alpha.
authors.forename: M H
authors.initials: MH
authors.lastname: Fenner
authors.forename: E L
authors.initials: EL
authors.lastname: Hänninen
authors.forename: H H
authors.initials: HH
authors.lastname: Kirchner
authors.forename: H
authors.initials: H
authors.lastname: Poliwoda
authors.forename: J
authors.initials: J
authors.lastname: Atzpodien
mesh_terms: D003072:Cognition Disorders / Q000139:chemically induced*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced*
chemical_list: D016898:Interferon-alpha; D007376:Interleukin-2